An Update on Impacts of Epigallocatechin Gallate Co-administration in Modulating Pharmacokinetics of Statins, Calcium Channel Blockers, and Beta-blockers
Planta Medica · 01.10.2023 · 89 (13) · 1229-1235
DOI: 10.1055/a-2111-7319 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Planta Medica, erschienen am 01.10.2023. Verfasst von Lee Siew-Keah und 4 weiteren Autor:innen. Beteiligte Einrichtung: M. Kandiah Faculty of Medicine and Health Sciences, Universiti Tunku Abdul Rahman, Kajang, Malaysia. Hauptthemen laut MEDLINE: Catechin, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Adrenergic beta-Antagonists, Calcium Channel Blockers. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: UTAR-Research Grant, Fundamental Research Grant Scheme, Ministry of Education, Malaysia..
Abstract (Originalsprache)
Brewed green tea, green tea extract, and its primary active compound, epigallocatechin gallate, may interact with drugs and alter the drugʼs therapeutic effectiveness, ultimately leading to therapeutic failure or drug overdose. Several isolated reports have claimed that epigallocatechin gallate is the main active ingredient that causes these effects. While a few studies aimed to uncover evidence of epigallocatechin gallate-drug interactions, no study has thoroughly and collectively reviewed them. Epigallocatechin gallate is a potential cardioprotective agent used by many patients with cardiovascular diseases as a complementary medicine alongside conventional modern medications, either with or without the knowledge of their physicians. Therefore, this review focuses on the impact of concurrent epigallocatechin gallate supplementation on pharmacokinetics and pharmacodynamics of several commonly used cardiovascular drugs (statins, beta-blockers, and calcium channel blockers). The PubMed index was searched for key words related to this review, without year limit, and the results were analyzed for interactions of cardiovascular drugs with epigallocatechin gallate. This review concludes that epigallocatechin gallate increases systemic circulation of several statins (simvastatin, fluvastatin, rosuvastatin) and calcium channel blockers (verapamil), but decreases the bioavailability of beta-blockers (nadolol, atenolol, bisoprolol). Further studies on its clinical significance in affecting drug efficacy are required.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- M. Kandiah Faculty of Medicine and Health Sciences, Universiti Tunku Abdul Rahman, Kajang, Malaysia.
- Faculty of Medicine, Universiti Teknologi MARA, Sungai Buloh, Malaysia.
- Faculty of Pharmacy, University of Cyberjaya, Cyberjaya, Malaysia.
- Faculty of Pharmaceutical Sciences, UCSI University, Kuala Lumpur, Malaysia.
Förderung
- UTAR-Research Grant
- Fundamental Research Grant Scheme, Ministry of Education, Malaysia.
Zitieren
APA
Siew-Keah, L., Jie, T. H., Ang-Lim, C., Bin, L. K., & Yik-Ling, C. (2023). An Update on Impacts of Epigallocatechin Gallate Co-administration in Modulating Pharmacokinetics of Statins, Calcium Channel Blockers, and Beta-blockers. Planta Medica, 89(13), 1229-1235. https://doi.org/10.1055/a-2111-7319
Vancouver
Siew-Keah L, Jie TH, Ang-Lim C, Bin LK, Yik-Ling C. An Update on Impacts of Epigallocatechin Gallate Co-administration in Modulating Pharmacokinetics of Statins, Calcium Channel Blockers, and Beta-blockers. Planta Medica. 2023;89(13):1229-1235. doi:10.1055/a-2111-7319
BibTeX
@article{SiewKeah2023,
author = {Siew-Keah, Lee and Jie, Tan Hong and Ang-Lim, Chua and Bin, Liew Kai and Yik-Ling, Chew},
title = {An Update on Impacts of Epigallocatechin Gallate Co-administration in Modulating Pharmacokinetics of Statins, Calcium Channel Blockers, and Beta-blockers},
journal = {Planta Medica},
year = {2023},
volume = {89},
number = {13},
pages = {1229--1235},
doi = {10.1055/a-2111-7319}
}
EUVIMED